JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1832 Doxorubicin (Adriamycin) HCl
9 Citation

Target: Topoisomerases

Summary: DNA topoisomerase II inhibitor

≥29 mg/mL
A1402 Gemcitabine HCl

Summary: Inhibits DNA synthesis,deoxycytidine analog

≥10.1 mg/mL
A2149 Bosutinib (SKI-606)
1 Citation

Target: Bcr-Abl|Src

Summary: Potent Abl/Src kinases

≥26.5 mg/mL
A2067 PI-103
1 Citation

Summary: Class I PI3K, mTOR and DNA-PK inhibitor

≥21.9 mg/mL
A2960 Loratadine

Target: Histamine H1 Receptors

Summary: Peripheral HH1R antagonist

insoluble in H2O; ≥19.14 mg/mL
A2307 PHA-665752
1 Citation

Target: c-MET

Summary: C-Met inhibitor,potent and ATP-competitive
A2942 Masitinib (AB1010)

Target: PDGFR|c-Kit|Lyn

Summary: Tyrosine kinase inhibitor, potent and selective

≥24.95 mg/mL
A2036 Doripenem Hydrate

Target: Antibiotic

Summary: Injectable antibiotic,ultra-broad spectrum

insoluble in EtOH; ≥10.96 mg/mL
A1389 WZ4002

Summary: Mutant-selective EGFR inhibitor(L858R,T790M), irreversible and potent

≥24.7 mg/mL
A1980 SNS-032 (BMS-387032)
2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor

insoluble in H2O; ≥19.05 mg/mL